QUEBEC CITY, Feb. 29 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS;
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, today announced the resignation of Mario Paradis, CA, the Company's
Senior Vice President, Administrative & Legal Affairs and Corporate Secretary.
Mr. Paradis has accepted the position of Vice President and Chief Financial
Officer of Atrium Innovations, a leading developer, manufacturer and marketer
of science-based products for the cosmetics, pharmaceutical, chemical and
nutrition industries. Mr. Paradis will remain in his capacity at the Company
through a transition period, and his departure will become effective in early
David J. Mazzo, Ph.D., President and CEO of AEterna Zentaris commented,
"We would like to extend our sincere appreciation to Mario for his dedication
and significant contributions to the evolution of AEterna Zentaris over the
years. We wish him well as he embarks on this new chapter in his career."
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization.
News releases and additional information are available at
This press release contains forward-looking statements made pursuant to
the safe harbor provisions of the U.S. Securities Litigation Reform Act of
1995. Forward-looking statements involve known and unknown risks and
uncertainties, which could cause the Company's actual results to differ
materially from those in the forward-looking statements. Such risks and
uncertainties include, among others, the availability of funds and resources
to pursue R&D projects, the successful and timely completion of clinical
studies, the ability of the Company to take advantage of business
opportunities in the pharmaceutical industry, uncertainties related to the
regulatory process and general changes in economic conditions. Investors
should consult the Company's quarterly and annual filings with the Canadian
and U.S. securities commissions for additional information on risks and
uncertainties relating to the forward-looking statements. Investors are
cautioned not to rely on these forward-looking statements. The Company does
not undertake to update these forward-looking statements. We disclaim any
obligation to update any such factors or to publicly announce the result of
any revisions to any of the forward-looking statements contained herein to
reflect future results, events or developments except if we are requested by a
governmental authority or applicable law.
For further information:
For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 626-5509, firstname.lastname@example.org;
Paul Burroughs, Media Relations, (418) 652-8525, ext. 406,